5th Annual Controlled & Modified Drug Release Summit is organized by Curtis & Coulter LLC and will be held from Nov 28 - 29, 2018 at Philadelphia Marriott Downtown, Philadelphia, Pennsylvania, United States of America.
The target audience for this medical event is Pharmaceutical, biotech and academic professionals specializing in : Drug Delivery, Pharmaceutics, PK-PD, Physiochemistry, Formulation / Pre-Formulation, Medicinal / Analytical / Solid state Chemistry, Preclinical / Analytical Development, Product Enhancement / Development, CMC, Regulatory Affairs, Drug Discovery, Life-Cycle / Portfolio Management, Partnering, Licensing & Alliance Management, Intellectual Property, Toxicology, Process R&D.
Conference Description :
Controlled ??& ??Modified ??Drug ??Release ??continues ??to ??be ??one ??of ??the ??most ??innovative ??areas ??in ??drug ??development. ??Oral ??modified ??release ??drug ??products ??account ??for ??one ??third ??of ??the ??drug ??product ??market. ??Successfully ??getting ??your ??modified ??release ??drugs ??to ??the ??market ??place ??has ??significant ??product ??lifecycle ??benefits, ??which ??will ??be ??shared ??at ?November's ??event.
Learn directly from the industry’s leading experts and hear unique case study sessions and take-home examples to enhance your product pipeline. Gather insights into the latest technologies and methods in improving drug release mechanisms, maximizing exposure, and reducing time-to-market. Additionally, this must-attend event will showcase the latest regulatory guidance updates and the implications for the industry.
This intensive 2-Day program will share innovative controlled and modified drug release strategies that will benefit your current and future product pipelines. Engage in dynamic conversation with your industry peers at our multiple networking sessions, and takeaway novel controlled and modified release strategies, which could speed up a time to market and save your organization millions.
You will learn:
• Precision medicine & healthcare delivery: making precision medicine a reality via novel technology advancements
• 3D printing for biopharmaceuticals: Next-generation industrial scale-up
• Localized & targeted delivery
• Modified delivery of next-generation products
• Regulatory guidance for modified release dosage forms
• Advances in ocular delivery
• Micro and nanoparticle delivery
• Parenteral routes of administration
• Topical and transdermal delivery
• Oral peptide commercialization and delivery
• Enhancing patient adherence via drug delivery
• Oral drug formulation and delivery technologies
• In-Vivo animal models & physiologically-based PBPK modelling
• Implementing innovative strategies around drug/device combinations
• Controlled delivery to enhance product lifecycle
• Pediatric dosage forms & delivery
• Enhancing macromolecule delivery
Additional details will be posted as soon as they are available.